GRMN vs SMMT · P/E 28, rev $7.25B vs $11.46B cap
Garmin Ltd (GRMN) versus Summit Therapeutics PLC (SMMT) — a side-by-side from cached financials, not a winner call.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
Summit Therapeutics PLC (SMMT) is a biotechnology company listed on US.
Latest reported GRMN revenue for 2025-12-27 was $7.25B. Net income was $1.66B. Revenue was up 15.1% from 2024-12-28 to 2025-12-27. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
SMMT does not have a complete income-statement cache yet.
GRMN currently screens at market cap $41.35B and trailing P/E 28.3. SMMT currently screens at market cap $11.46B.
Not investment advice. Open the GRMN and SMMT stock pages for the full models.
Not investment advice.